Letter to the Editor

Outcome Predictors of Chronic Renal Disease Patients with Parapneumonic Empyemas

Authors: Chia-Hung Chen, MD, Chih-Yen Tu, MD, Yi-Heng Liu, MD


To the Editor:

Bacterial infections are a well-documented complication in chronic kidney disease (CKD) patients,1 but to our knowledge, no study has focused on parapneumonic empyemas in these patients. We designed a retrospective study to investigate the bacteriology and outcome predictors of parapneumonic empyemas in patients with stage 4 or 5 CKD.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1.Chen KY, Hsueh PR, Liaw YS, et al. A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest 2000;117:1685–1689.
2.Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis 1993;148:813–817.
3.Varkey B, Rose HD, Kutty CP, et al. Empyema thoracis during a ten-year period: analysis of 72 cases and comparison to a previous study (1952–1967). Arch Intern Med 1981;141:1771–1776.
4.Albrecht SJ, Fishman NO, Kitchen J, et al. Reemergence of gram-negative health care-associated bloodstream infections. Arch Intern Med 2006;166:1289–1294.